Imaging of cardiovascular complications in patients with systemic lupus erythematosus

Area of Science:

• Cardiology
• Rheumatology
• Medical Imaging

Background:

• Cardiovascular disease (CVD) is a primary cause of mortality in patients with systemic lupus erythematosus (SLE).
• Both traditional CVD risk factors and SLE-specific conditions contribute to increased cardiovascular risk in these patients.
• Multimodality cardiovascular imaging is increasingly used to evaluate cardiovascular risk in SLE.

Purpose of the Study:

• To review cutting-edge cardiovascular imaging techniques for evaluating SLE-related heart disorders.
• To discuss the potential clinical applications and limitations of these imaging methods.
• To highlight the role of quantitative imaging biomarkers in risk stratification and guiding SLE management.

Main Methods:

• Review of current literature on cardiovascular imaging in SLE.
• Discussion of multimodality imaging techniques (e.g., echocardiography, cardiac MRI, CT).
• Focus on quantitative imaging biomarkers for morphological and functional cardiac assessment.

Main Results:

• Quantitative imaging biomarkers offer novel insights into cardiac abnormalities in SLE.
• Imaging can help stratify cardiovascular risk beyond traditional factors.
• Assessment of individual responses to therapies targeting cardiovascular protection or autoimmune suppression is feasible.

Conclusions:

• Advanced cardiovascular imaging techniques are crucial for managing SLE patients.
• Quantitative biomarkers derived from imaging can personalize SLE management and improve long-term survival.
• Further research is needed to fully elucidate the clinical utility and limitations of these techniques.